Drug name - Genvoya

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US7176220 GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent
Aug, 2026

(3 years from now)

US8981103 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US7635704 GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound
Oct, 2026

(4 years from now)

US8148374 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101796040A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100375742C GILEAD SCIENCES INC 4-Oxo-Quinoline Compound And Use Thereof
Jan, 2023

(3 months from now)

CN1692101A GILEAD SCIENCES INC 4-Oxo-Quinoline Compounds And Their Use As Hiv Integrase Inhibitors
Jan, 2023

(3 months from now)

CN1956961B GILEAD SCIENCES INC 4 Compound Of Stable Crystal
May, 2025

(2 years from now)

CN1956961A GILEAD SCIENCES INC Stable Crystal Form Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

CN101679325A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B GILEAD SCIENCES INC Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101679325B GILEAD SCIENCES INC Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200401316P4 GILEAD SCIENCES INC 4-Oxoquinoline Compound And Use Thereof As Pharmaceutical Agent
Nov, 2023

(1 year, 1 month from now)

IN245833B GILEAD SCIENCES INC 4-Oxoquinoline Compound As Hiv Integrase Inhibitor
Nov, 2023

(1 year, 1 month from now)

IN200810487P1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN332719B GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1636190B1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP1636190A1 GILEAD SCIENCES INC Stable Crystal Of 4-Oxoquinoline Compound
May, 2025

(2 years from now)

EP2487165A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2118082B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP1564210B9 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210B1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A4 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP1564210A1 GILEAD SCIENCES INC 4-Oxoquinoline Compounds And Utilization Thereof As Hiv Integrase Inhibitors
May, 2028

(5 years from now)

EP2170851B1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 GILEAD SCIENCES INC Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US7176220

(Pediatric)

GILEAD SCIENCES INC 4-oxoquinoline compound and use thereof as pharmaceutical agent Feb, 2027

(4 years from now)

US7635704

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US8981103

(Pediatric)

GILEAD SCIENCES INC Stable crystal of 4-oxoquinoline compound Apr, 2027

(4 years from now)

US9891239 GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Sep, 2029

(6 years from now)

US8148374

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US9891239

(Pediatric)

GILEAD SCIENCES INC Modulators of pharmacokinetic properties of therapeutics Mar, 2030

(7 years from now)

US8633219 GILEAD SCIENCES INC Combination therapy Apr, 2030

(7 years from now)

US8633219

(Pediatric)

GILEAD SCIENCES INC Combination therapy Oct, 2030

(8 years from now)

US10039718 GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US10039718

(Pediatric)

GILEAD SCIENCES INC Use of solid carrier particles to improve the processability of a pharmaceutical agent Apr, 2033

(10 years from now)

More Information on Dosage
Strength Dosage Availability
150MG;150MG;200MG;EQ 10MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.